The FDA today issued a public health advisory about reports of a rare brain infection in people using the psoriasis drug Raptiva.
According to the FDA, there have been three confirmed and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva; three of those people died.
Psoriasis Drug Raptiva Tied to Brain Infection
Air in the U.S. has gotten cleaner for decades, adding years to people's lives and preventing...
The US supreme court on Monday heard arguments in a case that could threaten Americans’ access...
